The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Human interferon consensus sequence binding protein is a negative regulator of enhancer elements common to interferon-inducible genes.
Open accessAbstract
The promoter regions of many interferon-inducible genes share a short DNA sequence motif, termed the interferon consensus sequence (ICS) to which several regulatory proteins bind. A murine cDNA which encodes an ICS binding protein has been reported (M-ICSBP). The cloning of the human homologue of ICSBP (H-ICSBP) is described. H-ICSBP shares high sequence homology with its murine cognate. The derived sequence of H-ICSBP reveals restricted homology within the first 120 amino acids to three other interferon regulatory factors, IRF-1, IRF-2, and ISGF3 gamma. Truncated ICSBP lacking the first 33 amino-terminal amino acids fails to bind to the ICS, indicating that at least part of the DNA binding domain is located within the well conserved amino terminus. H-ICSBP is expressed exclusively in cell lines of hematopoietic origin. The results of transient transfection assays carried out either in hematopoietic or nonhematopoietic cells suggest that ICSBP acts as a negative regulatory factor on ICS-containing promoters. Furthermore, either interferon-gamma (IFN-gamma) or IFN-beta can alleviate the repression mediated by ICSBP. Therefore, ICSBP may be involved in maintaining submaximal transcriptional activity of IFN-inducible genes in hematopoietic cells. IFN treatment would then alleviate repression allowing maximal transcriptional activity of these genes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Likewise, previous reporter analysis indicated that ICSBP is a repressor of ISRE-dependent transcription (36, 57).”
From Gamma Interferon Triggers Interaction between ICSBP (IRF-8) and TEL, Recruiting the Histone Deacetylase HDAC3 to the Interferon-Responsive Element (2002) · cites this paper as [57]
In the citing paper
“transfection of ICSBP alone reduced ISRE reporter activity by ∼ 40% irrespective of IFN𝛄 treatment, consistent with the previous finding that ICSBP represses ISRE-dependent transcription (36, 57).”
From Gamma Interferon Triggers Interaction between ICSBP (IRF-8) and TEL, Recruiting the Histone Deacetylase HDAC3 to the Interferon-Responsive Element (2002) · cites this paper as [57]
In the citing paper
“Interferon (IFN) consensus sequence binding protein (ICSBP)/IFN regulatory factor (IRF)-8 is an IFN g -inducible transcription factor of the IRF family and regulates transcription through multiple target DNA elements, such as IFN-stimulated response element (ISRE), Ets/IRF composite element, and IFNg activation site (GAS).”
From Review: ICSBP/IRF-8: Its Regulatory Roles in the Development of Myeloid Cells (2002) · cites this paper as [6]
In the citing paper
“ICSBP is expressed in the hematopoietic cells, including cells of the monocyte/macrophage lineage, B lymphocytes, and activated T lymphocytes, and is inducible by IFNg in these cells, suggesting its role in immune cells. (6,9-13)”
From Review: ICSBP/IRF-8: Its Regulatory Roles in the Development of Myeloid Cells (2002) · cites this paper as [6]
In the citing paper
“Subsequent studies have shown that ICSBP is a transcriptional repressor acting through the IFN-stimulated response element (ISRE). (6,20,21)”
From Review: ICSBP/IRF-8: Its Regulatory Roles in the Development of Myeloid Cells (2002) · cites this paper as [6]
Citations
Cites
PCR protocols — A guide to methods and applications
U.G. (1990) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(90)90252-7 · Cited by 11,751
Shaw, G. D., & Kamen, R. (1986) · Cell · doi:10.1016/0092-8674(86)90341-7 · Cited by 3,946
Pestka, S., Langer, J. A., Zoon, K. C., & Samuel, C. E. (1987) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.56.070187.003455 · Cited by 1,826
Harada, H., Fujita, T., Miyamoto, M., Kimura, Y., Maruyama, M., Furia, A., Miyata, T., & Taniguchi, T. (1989) · Cell · doi:10.1016/0092-8674(89)90107-4 · Cited by 957
Two distinct enhancers with different cell specificities coexist in the regulatory region of polyoma
Herbomel, P., Bourachot, B., & Yaniv, M. (1984) · Cell · doi:10.1016/0092-8674(84)90472-0 · Cited by 888
Electroporation for the efficient transfection of mammalian cells with DNA
Chu, G., Hayakawa, H., & Berg, P. (1987) · Nucleic Acids Research · doi:10.1093/nar/15.3.1311 · Cited by 851
Andrews, P. W. (1984) · Developmental Biology · doi:10.1016/0012-1606(84)90316-6 · Cited by 806
Uzé, G., Lutfalla, G., & Gresser, I. (1990) · Cell · doi:10.1016/0092-8674(90)90738-z · Cited by 584
Levy, D. E., Kessler, D. S., Pine, R. I., Reich, N. C., & Darnell, J. E., Jr. (1988) · Genes & Development · doi:10.1101/gad.2.4.383 · Cited by 559
Friedman, R. L., & Stark, G. R. (1985) · Nature · doi:10.1038/314637a0 · Cited by 491
Research works printed but not linked: 8
- Levy, 1990, New Biologist, 2, 923
- Lew, 1991, Mol. Cell. Biol., 11, 182
- Minowada, J., Sagawa, K., Lok, M. S., Kubonishi, I., Nakazawa, S., Tatsumi, E., Ohnuma, T., and Goldblum, N. (1980) in International Symposium on New Trends in Human Immunology and Cancer Immunotherapy (Srrou, B., and Rosenfeld, C., eds) pp. 188–199, doin editeurs, Paris
- Gutkind, 1991, Mol. Cell. Biol, 11, 1500
- Pahl, 1991, Exp. Hematol., 19, 1038
- Veals, 1991, J. Interferon Res., 11, S82
- Veals, 1992, Mol. Cell. Biol., 12, 3315
- Hoffmann, 1991, J. Interferon Res., 11, S139
Cited by
Sorted by citations
Items 101–152 of 152
In vivo formation of IRF-1 homodimers
Kirchhoff, S., Schaper, F., Oumard, A., & Häuser, H. (1998) · Biochimie · doi:10.1016/s0300-9084(99)80019-4 · Cited by 20
Cloning of an interferon regulatory factor 2 isoform with different regulatory ability
Merediz, S. A. K. X. F. N. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.21.4219 · Cited by 20
Eklund, E. A., & Kakar, R. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.14.9344 · Cited by 18
Interferons Alpha, Beta, and Omega
Meager, A. (1998) · Elsevier eBooks · doi:10.1016/b978-012498340-3/50026-9 · Cited by 18
Waring, J. F., Radford, J. E., Burns, L. J., & Ginder, G. D. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.20.12276 · Cited by 18
Host Immunosurveillance Controls Tumor Growth via IFN Regulatory Factor-8–Dependent Mechanisms
Greeneltch, K. M., Schneider, M., Steinberg, S. M., Liewehr, D. J., Stewart, T. J., Liu, K., & Abrams, S. I. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1228 · Cited by 19
The effect of IFNγ on the hepatocyte: cell cycle and apoptosis
Tura, B. J., Bunyan, K. E., & Harrison, D. J. (2001) · International Journal of Experimental Pathology · doi:10.1046/j.1365-2613.2001.00207.x · Cited by 17
Kanno, Y., Kozak, C. A., Schindler, C., Driggers, P., Ennist, D. L., Gleason, S., Darnell, J. E., & Ozato, K. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.7.3951-3963.1993 · Cited by 185
Self-citationAdvances in the Xenopus immunome: Diversification, expansion, and contraction
Dimitrakopoulou, D., Khwatenge, C. N., James‐Zorn, C., Paiola, M., Bellin, E. W., Tian, Y., Sundararaj, N., Polak, E. J., Grayfer, L., Barnard, D. C., et al. (2023) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2023.104734 · Cited by 15
Ueno, M., Sonoda, Y., Funakoshi, M., Mukaida, N., Nose, K., & Kasahara, T. (2000) · Cytokine · doi:10.1006/cyto.1999.0544 · Cited by 16
Shin, G. W., White, S. L., Dahms, H.-U., Jeong, H. D., & Kim, J. (2013) · Journal of Fish Diseases · doi:10.1111/jfd.12182 · Cited by 15
FEIGENBLUM, D. Y., WALKER, R. E., & Schneider, R. J. (1998) · Journal of Virology · doi:10.1128/jvi.72.11.9257-9266.1998 · Cited by 15
Roles of IRF4 in various immune cells in systemic lupus erythematosus
Xiao, Z. X., Liang, R., Olsen, N. J., & Zheng, S. G. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.112077 · Cited by 14
Differentially expressed cellular genes following HBV: potential targets of anti‐HBV drugs?
Yang, J., Bo, X., Yao, J., Yang, N., & Wang, S. Q. (2005) · Journal of Viral Hepatitis · doi:10.1111/j.1365-2893.2005.00611.x · Cited by 13
Shin, H. S., Drysdale, B. E., Shin, M. L., Noble, P. W., Fisher, S. N., & Paznekas, W. A. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.5.2914-2925.1994 · Cited by 13
Dual-Stream Subspace Clustering Network for revealing gene targets in Alzheimer's disease
Chen, M., Jia, S., Xue, M., Huang, H., Xu, Z., Yang, D., Zhu, W., & Song, Q. (2022) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2022.106305 · Cited by 12
Dimberg, A., Kårehed, K., Nilsson, K., & Oberg, F. G. (2006) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.2006.01827.x · Cited by 12
Nakano, N., Nishiyama, C., Masuoka, N., Nishiyama, M., Yamane, H., Okumura, K., & Ogawa, H. (2005) · Immunogenetics · doi:10.1007/s00251-004-0754-2 · Cited by 11
Dosch, E., Zöller, B., Redmann-Müller, I., Nanda, I., Schmid, M., Viciano-Gofferge, A., & JUNGWIRTH, C. (1998) · Gene · doi:10.1016/s0378-1119(98)00063-8 · Cited by 11
Cai, M., & Chen, N. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.817069 · Cited by 10
Sung, J. Y., Kim, H., Kim, Y.-N., Na, Y. S., & Park, B.-K. (2011) · Laboratory Investigation · doi:10.1038/labinvest.2011.90 · Cited by 10
Sp2 regulates interferon-γ-mediated socs1 gene expression
Letourneur, M., Valentino, L., Travagli-Gross, J., Bertoglio, J. H., & Pierre, J. (2009) · Molecular Immunology · doi:10.1016/j.molimm.2009.05.004 · Cited by 12
Transcriptional repression of type I IFN genes
Lopez, S., & Navarro, S. (1998) · Biochimie · doi:10.1016/s0300-9084(99)80022-4 · Cited by 10
ICSBP promoter methylation in myelodysplastic syndromes and acute myeloid leukaemia
Otto, N., Manukjan, G., Göhring, G., Hofmann, W. A., Scherer, R., Luna, J., Lehmann, U., Ganser, A., Welte, K., Schlegelberger, B., et al. (2011) · Leukemia · doi:10.1038/leu.2011.61 · Cited by 9
Taaffe, J. E., Bosinger, S. E., Prete, G. Q. D., Else, J. G., Ratcliffe, S. J., Ward, C. D. W., Migone, T., Paiardini, M., & Silvestri, G. (2011) · Journal of Medical Primatology · doi:10.1111/j.1600-0684.2011.00521.x · Cited by 9
Immunotherapy in Chronic Myelogenous Leukemia
Guilhot, F., Roy, L., Martineau, G., Guilhot, J., & Millot, F. (2007) · Clinical Lymphoma & Myeloma · doi:10.3816/clm.2007.s.004 · Cited by 9
Ma, S. L., Sørensen, A. B., Kunder, S., Sørensen, K. D., Quintanilla‐Martínez, L., Morris, D. W., Schmidt, J., & Pedersen, F. S. (2006) · Virology · doi:10.1016/j.virol.2006.05.006 · Cited by 8
Moassass, F., Wafa, A., Liehr, T., Al-Ablog, A., & Achkar, W. A. (2018) · Molecular Cytogenetics · doi:10.1186/s13039-018-0370-8 · Cited by 8
STEM CELLS IN CHRONIC MYELOGENOUS LEUKEMIA
Verfaillie, C. M. (1997) · Hematology/Oncology Clinics of North America · doi:10.1016/s0889-8588(05)70484-6 · Cited by 8
Chang, K., Han, K. S., Qiu, W., Hu, Z., Chen, X., Chen, X., Xie, X., Wang, S., Hu, C., & Mao, H. (2021) · Molecular Immunology · doi:10.1016/j.molimm.2021.04.020 · Cited by 6
The Making of a cDC1 : Precision Programming of Progenitor Potential
Murphy, T. L., & MURPHY, K. M. M. (2025) · Immunological Reviews · doi:10.1111/imr.70081 · Cited by 8
Signaling Molecules Affecting Immune Response
Hertzog, P. J., Fenner, J. E., & Mansell, A. S. (2005) · Elsevier eBooks · doi:10.1016/b978-012455900-4/50267-1 · Cited by 4
Construction of irf4a Transgenic Zebrafish Using Tol2 System and Its Potential Application
Gou, Y., Sun, W., Liu, L., Zhang, M., Du, J., Wang, R., & Xu, X. (2020) · Dose-Response · doi:10.1177/1559325820926733 · Cited by 3
Revel, M. (1997) · Growth factors and cytokines in health and disease · doi:10.1016/s1874-5687(97)80034-1 · Cited by 3
Silverman, N. (2006) · Digital Commons - University of South Florida (University of South Florida) · Cited by 2
Manipulation of Macrophage Activities Using Liposomes
Honing, H., van Rooijen, N., & van den Berg, T. K. (2000) · Journal of Liposome Research · doi:10.3109/08982100009031105 · Cited by 2
Rubinstein, Y., & Pontzer, C. H. (2000) · Antiviral Research · doi:10.1016/s0166-3542(00)00087-5 · Cited by 2
IRF7 links HK1-dependent histone lactylation to fibroblast activation and cardiac fibrosis
Kong, M., Zhu, C., Xue, Y., Hong, W., Zhang, G., Jiang, D., Xu, Y., & Guo, J. (2026) · EMBO Molecular Medicine · doi:10.1038/s44321-026-00444-2 · Cited by 1
Cis- and trans-regulation of Irf8 enhancers during dendritic cell development
Nishiyama, A., & Tamura, T. (2025) · Experimental Hematology · doi:10.1016/j.exphem.2025.104858 · Cited by 1
A functional ISRE is required for myeloid transcription of the p47phox gene
Marden, C. M., Graham, D. S. C., Thrasher, A. J., & Casimir, C. M. (2003) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/j.bbaexp.2003.09.005 · Cited by 1
Mechanisms of Transcriptional Regulation
Marecki, S., & Fenton, M. J. (2000) · Cited by 2
Regulation of transcription and analysis of drug targets in lymphoma and myeloma cells
Bolick, S. C. E. (2006) · Digital Commons - University of South Florida (University of South Florida)
Expression and activation of STAT and IRF family transcription factors in mononuclear leukocytes
Lehtonen, A. (2005) · Työväentutkimus Vuosikirja
TUMOR-BEARING HOST MACROPHAGE DYSFUNCTION: ROLE OF
Martins, R. S. (2001)
Tumor-Bearing Host Macrophage Dysfunction: Role of CD40/CD40L Interactions
Martins, R. S. (2001) · VTechWorks (Virginia Tech)
Nontuberculosis Mycobacterial Disease
Martiniano, S. L., Nick, J. A., & Daley, C. L. (2019) · Elsevier eBooks · doi:10.1016/b978-0-323-44887-1.00030-4
Genetics of Multiple Sclerosis
Leppä, V. (2013) · Työväentutkimus Vuosikirja
Genes of the Major Histocompatibility Complex
(1998) · Springer eBooks · doi:10.1007/978-0-585-31180-7_1
Kim, S. K., Liu, T., Ou, F., Murphy, T. L., & MURPHY, K. M. M. (2024) · Advances in immunology · doi:10.1016/bs.ai.2024.08.001 · Cited by 1
Epigenetic regulation of gene transcription in hematopoietic tumors.
Tshuikina, M. (2008) · KTH Publication Database DiVA (KTH Royal Institute of Technology)
Human inherited IRF1 deficiency
Rosain, J. (2022) · theses.fr (ABES) · doi:10.70675/067993b6zab73z45fazb9aez6af7872f8ba2
Metadata
- Authors
- Weisz, A., Marx, P., Sharf, R., Appella, E., Driggers, P. H., Ozato, K., & Levi, B. Z.
- Affiliations
- Technion – Israel Institute of Technology (IL)
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 1992-12
- Volume
- 267
- Issue
- 35
- Pages
- 25589-25596
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W1528284784
- Cited by
- 152
- References
- 39
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 2 · 2023: 1 · 2022: 5 · 2021: 1 · 2020: 1 · 2019: 1 · 2018: 2 · 2016: 2 · 2014: 3 · 2013: 4 · 2012: 2
- FWCI
- 2.86
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
- Keywords
- IRF8, interferon-stimulated genes, enhancer repression, negative transcriptional regulation, interferon regulatory factors, IRF1, IRF2, DNA-binding domain, hematopoietic cells, interferon-gamma, interferon-beta, transcriptional regulation
- MeSH terms
- Interferon Regulatory Factor-8, Amino Acid Sequence, Base Sequence, beta-Galactosidase, Carrier Proteins, Cell Line, Cycloheximide, DNA, DNA-Binding Proteins, Enhancer Elements, Genetic, HeLa Cells, Humans, Interferon-gamma, Lung, Molecular Sequence Data, Plasmids, Promoter Regions, Genetic, Recombinant Proteins, Repressor Proteins, RNA, Messenger, Transfection, Tumor Cells, Cultured, Blotting, Northern, Chloramphenicol O-Acetyltransferase, Gene Library, Gene Expression Regulation, Neoplastic, Interferon-beta, Sequence Homology, Amino Acid, Interferon Regulatory Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
